Banque Cantonale Vaudoise bought a new stake in Ventas, Inc. (NYSE:VTR – Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 7,621 shares of the real estate investment trust’s stock, valued at approximately $623,000.
Several other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. boosted its position in shares of Ventas by 3.2% in the 4th quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock worth $5,876,856,000 after purchasing an additional 2,349,176 shares during the last quarter. State Street Corp grew its position in shares of Ventas by 2.5% in the 4th quarter. State Street Corp now owns 29,662,635 shares of the real estate investment trust’s stock valued at $2,309,234,000 after purchasing an additional 735,620 shares during the period. Geode Capital Management LLC raised its holdings in Ventas by 3.8% during the 4th quarter. Geode Capital Management LLC now owns 12,988,943 shares of the real estate investment trust’s stock worth $1,001,447,000 after buying an additional 475,633 shares during the period. Price T Rowe Associates Inc. MD lifted its stake in Ventas by 27.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 9,176,254 shares of the real estate investment trust’s stock valued at $710,060,000 after buying an additional 2,000,341 shares in the last quarter. Finally, Capital World Investors bought a new stake in Ventas in the 4th quarter valued at $594,116,000. Institutional investors own 94.18% of the company’s stock.
Analysts Set New Price Targets
VTR has been the subject of several research reports. Citigroup raised their price target on shares of Ventas from $96.00 to $100.00 and gave the stock a “buy” rating in a research note on Friday, May 1st. BMO Capital Markets reaffirmed an “outperform” rating and issued a $100.00 target price on shares of Ventas in a report on Monday, May 4th. UBS Group increased their price target on Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a research note on Monday, May 4th. The Goldman Sachs Group reiterated a “buy” rating and set a $110.00 target price on shares of Ventas in a research note on Tuesday, May 19th. Finally, Scotiabank decreased their target price on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating on the stock in a research report on Thursday, June 18th. Fifteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $96.00.
Insiders Place Their Bets
In related news, Director Michael J. Embler acquired 2,500 shares of the stock in a transaction on Wednesday, June 3rd. The stock was purchased at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the transaction, the director owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This trade represents a 14.97% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Walter C. Rakowich sold 1,152 shares of the company’s stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the transaction, the director owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. This represents a 3.90% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.53% of the company’s stock.
Ventas Stock Performance
Shares of VTR stock opened at $89.06 on Monday. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95. Ventas, Inc. has a 52 week low of $61.76 and a 52 week high of $91.06. The firm has a 50 day moving average of $85.21 and a 200-day moving average of $82.80. The company has a market cap of $43.30 billion, a price-to-earnings ratio of 161.92, a price-to-earnings-growth ratio of 1.91 and a beta of 0.71.
Ventas (NYSE:VTR – Get Free Report) last issued its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.59 billion. Ventas had a return on equity of 2.09% and a net margin of 4.25%.Ventas’s revenue for the quarter was up 22.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, equities analysts forecast that Ventas, Inc. will post 3.88 earnings per share for the current year.
Ventas Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be given a $0.52 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 annualized dividend and a dividend yield of 2.3%. Ventas’s payout ratio is 378.18%.
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Further Reading
- Five stocks we like better than Ventas
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
